Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 6 » default
Psoriasis: Targets and Therapy
ISSN: 2230-326X
- View all (136)
- Volume 14, 2024 (3)
- Volume 13, 2023 (7)
- Volume 12, 2022 (22)
- Volume 11, 2021 (14)
- Volume 10, 2020 (8)
- Volume 9, 2019 (13)
- Volume 8, 2018 (12)
- Volume 7, 2017 (9)
- Volume 6, 2016 (15)
- Volume 5, 2015 (13)
- Volume 4, 2014 (5)
- Volume 3, 2013 (4)
- Volume 2, 2012 (10)
- Volume 1, 2011 (1)
Archive: Volume 6, 2016
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T
Psoriasis: Targets and Therapy 2016, 6:165-173
Published Date: 12 December 2016
Tacrolimus for the management of psoriasis: clinical utility and place in therapy
Malecic N, Young H
Psoriasis: Targets and Therapy 2016, 6:153-163
Published Date: 7 December 2016
Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
el Hayderi L, Colson F, Dezfoulian B, Nikkels AF
Psoriasis: Targets and Therapy 2016, 6:145-151
Published Date: 18 October 2016
Pustular psoriasis: pathophysiology and current treatment perspectives
Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B
Psoriasis: Targets and Therapy 2016, 6:131-144
Published Date: 12 September 2016
Psoriasis in children
Pinson R, Sotoodian B, Fiorillo L
Psoriasis: Targets and Therapy 2016, 6:121-129
Published Date: 20 October 2016
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
Svendsen MT, Andersen KE, Andersen F, Hansen J, Pottegård A, Johannessen H
Psoriasis: Targets and Therapy 2016, 6:113-119
Published Date: 23 August 2016
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J
Psoriasis: Targets and Therapy 2016, 6:105-111
Published Date: 28 July 2016
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W
Psoriasis: Targets and Therapy 2016, 6:93-104
Published Date: 20 July 2016
Psoriasis and inflammatory bowel disease: links and risks
Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID
Psoriasis: Targets and Therapy 2016, 6:73-92
Published Date: 20 July 2016
Psoriasis and smoking: links and risks
Naldi L
Psoriasis: Targets and Therapy 2016, 6:65-71
Published Date: 27 May 2016
Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects
Franken SM, Vierstra CL, Rustemeyer T
Psoriasis: Targets and Therapy 2016, 6:55-64
Published Date: 18 May 2016
Assessment and monitoring of biologic drug adverse events in patients with psoriasis
Hanley T, Handford M, Lavery D, Yiu ZZN
Psoriasis: Targets and Therapy 2016, 6:41-54
Published Date: 1 April 2016
Management of scalp psoriasis: current perspectives
Blakely K, Gooderham M
Psoriasis: Targets and Therapy 2016, 6:33-40
Published Date: 29 March 2016
Current knowledge on psoriasis and autoimmune diseases
Ayala-Fontánez N, Soler DC, McCormick TS
Psoriasis: Targets and Therapy 2016, 6:7-32
Published Date: 22 February 2016
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
Landriscina A, Friedman AJ
Psoriasis: Targets and Therapy 2016, 6:1-5
Published Date: 19 January 2016